@article{9a483529-e037-4afb-8cce-ffa27461c5ae,
author = {Hanna  Wüller, Christoph  Sowada , Tomasz Bochenek},
title = {Comparison between processes of HTA, pharmaceutical pricing and reimbursement, and their transparency in Germany and Poland},
journal = {Public Health and Governance},
volume = {2015},
number = {Volume 13, Issue 1},
year = {2015},
issn = {1731-7398},
pages = {102-108},keywords = {health technology assessment; Germany; pharmaceutical policy; Poland pricing and reimbursement of pharmaceuticals; transparency},
abstract = {This paper focuses on HTA, pricing and reimbursement of pharmaceuticals in Germany and Poland. The authors analyzed processes of decision making related to pharmaceutical reimbursement, as well as their transparency. Both Germany and Poland have developed complex processes of pharmaceutical pricing and reimbursement, as well as incorporated HTA into decision making procedures.In Germany the stakeholders involvement and transparency of processes seem to be to higher than in Poland.},
doi = {10.4467/20842627OZ.15.010.4123},
url = {https://ejournals.eu/en/journal/zdrowie-publiczne-i-zarzadzanie/article/comparison-between-processes-of-hta-pharmaceutical-pricing-and-reimbursement-and-their-transparency-in-germany-and-poland}
}